Anelixis Therapeutics' Unattributed Round

Anelixis Therapeutics raised a round of funding on April 25, 2018.

Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatmen…

Articles about Anelixis Therapeutics' Unattributed Round: